Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis
New insights into the mechanisms of action of topical administration of GLP-1 in an experimental model of diabetic retinopathy
Published March 17, 2026 - More info Glucagon-like peptide-1 (GLP-1) and glucose-induced insulinotropic polypeptide (GIP) receptor agonists have revolutionized obesity therapy, but causes of obesity-associated dysregulation of endogenous incretin production remain incompletely understood
Eric Topol (04:40): Oh, yeah
The ongoing evolution of medical science provides innovative solutions, and with a holistic approach to care, individuals can navigate the path to improved well-being, one injection at a time
US$ 22.94
US$ 23.50
US$ 28.82
US$ 24.17
US$ 29.13
